Rosenson, R. S., Jacobson, T. A., Preiss, D., Djedjos, S. C., Dent, R., Bridges, I., & Miller, M. (2016). Erratum to: Efficacy and Safety of the PCSK9 Inhibitor Evolocumab in Patients with Mixed Hyperlipidemia. Cardiovasc Drugs Ther.
Styl cytowania ChicagoRosenson, Robert S., Terry A. Jacobson, David Preiss, Stephen C. Djedjos, Ricardo Dent, Ian Bridges, i Michael Miller. "Erratum To: Efficacy and Safety of the PCSK9 Inhibitor Evolocumab in Patients With Mixed Hyperlipidemia." Cardiovasc Drugs Ther 2016.
Styl cytowania MLARosenson, Robert S., et al. "Erratum To: Efficacy and Safety of the PCSK9 Inhibitor Evolocumab in Patients With Mixed Hyperlipidemia." Cardiovasc Drugs Ther 2016.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..